Delta-11-Tetrahydrocannabinol

Delta-11-Tetrahydrocannabinol (Delta-11-THC, Δ¹¹-THC, Δ⁹⁽¹¹⁾-THC, exo-Tetrahydrocannabinol) is a rare isomer of tetrahydrocannabinol, developed in the 1970s. It can be synthesised from Δ⁸-THC by several different routes, though only the (6aR, 10aR) enantiomer is known. In recent studies in 2022 it was found to "significantly reduce" the effects of Δ⁹-THC and has been suggested as antagonist of the CB1 receptor in humans, with the cited study showing "one partial success in the quest for an antagonist is the fact that D9,11-THC was found to significantly reduce the effect of D9-THC." and did not substitute for THC in rhesus monkeys. It has been identified as a component of grey market vaping liquids sold for use in humans.

See also

• Abeo-HHC acetate
• Cis-THC
• Delta-3-Tetrahydrocannabinol
• Delta-4-Tetrahydrocannabinol
• Delta-7-Tetrahydrocannabinol
• Delta-10-Tetrahydrocannabinol
• Hexahydrocannabinol
• Iso-THC
• L-759,656

References

1. Δ-8-Tetrahydrocannabinol
2. 11-Hydroxy-THC
3. Tetrahydrocannabinol
4. 11-Nor-9-carboxy-THC
5. Δ-10-Tetrahydrocannabinol
6. Δ-7-Tetrahydrocannabinol
7. Abeo-HHC acetate
8. 11-Hydroxy-Delta-8-THC
9. Dronabinol
10. Δ-4-Tetrahydrocannabinol
11. Δ-3-Tetrahydrocannabinol
12. Tetrahydrocannabutol
13. Hexahydrocannabinol
14. Lenabasum
15. 11-Hydroxyhexahydrocannabinol
16. Cis-THC
17. HU-210
18. Cannabinoid
19. Tetrahydrocannabihexol
20. Psychotomimetism